Literature DB >> 23607318

Post-cervical conization outcomes in patients with high-grade intraepithelial lesions.

Renata B Simões1, Adriana B Campaner.   

Abstract

To investigate the rates of residual, recurrent and invasive disease after cervical conization in patients diagnosed with cervical intraepithelial neoplasia (CIN) grades 2/3. A retrospective study was conducted with 274 patients undergoing cervical conization due to diagnosis of CIN 2/3. Cervical conization was done through the Loop Electrosurgical Excision Procedure (LEEP) and Cold Knife Conization. Data related to personal, familial, gynecological, and obstetric antecedents, as well as surgical specimens margins were collected from medical records. The outcome after conization was evaluated, including the time of follow-up and disease recurrence. The outcome after conization was not associated with age of menarche (p = 0.920), age of the first sexual intercourse (p = 0.533), number of parturition (p = 0.063), number of sexual partners (p = 0.328), immunosuppression (p = 0.225), smoking habit (p = 0.193), and conization type (p = 0.198). However, the outcome presented a significant association with age (p < 0.001), pregnancy numbers (p = 0.009), use of hormonal contraception methods (p = 0.016), menopause (p = 0.007), type of margins (p = 0.011), and cone histological results (p = 0.030). The routine control of all patients who had undergone cervical conization is obligate, independently of surgical margins, due to the risk of disease recurrence; the older patients and those with CIN 3 should have a more rigorous follow-up.
© 2013 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cervical intraepithelial neoplasia; cervical conization; epidemiology; outcome

Mesh:

Substances:

Year:  2013        PMID: 23607318     DOI: 10.1111/apm.12064

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  Risk Factors for Residual Disease in Hysterectomy Specimens After Conization in Post-Menopausal Patients with Cervical Intraepithelial Neoplasia Grade 3.

Authors:  Xiaoqi Sun; Huifang Lei; Xiaoyan Xie; Guanyu Ruan; Jian An; Pengming Sun
Journal:  Int J Gen Med       Date:  2020-11-10

2.  Association Between Positive Human Papillomavirus Status After Conization and Disease Recurrence in Patients with Cervical Intraepithelial Neoplasia Grade 3.

Authors:  Masaki Kamio; Shintaro Yanazume; Shinichi Togami; Hiroaki Kobayashi
Journal:  J Obstet Gynaecol India       Date:  2020-09-10

3.  Construction and Evaluation of a Clinical Prediction Scoring System for Positive Cervical Margins Under Colposcopy.

Authors:  Meiling Zhu; Mingyue Yu; Zhengzheng Chen; Weidong Zhao
Journal:  Front Med (Lausanne)       Date:  2022-02-28

4.  Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia.

Authors:  He Wang; Yanming Jiang; Yuejuan Liang; Lingjia Wei; Wei Zhang; Li Li
Journal:  BMC Cancer       Date:  2022-04-04       Impact factor: 4.430

5.  Risk factors predicting residual lesion in subsequent hysterectomy following cold knife conization (CKC) for high-grade squamous intraepithelial lesion (HSIL).

Authors:  Tao Jiang; Yong Zeng; Yahong Zheng; Jing Yang; Hua Wei; Cunjian Yi; Yan Liu; Keming Chen
Journal:  BMC Womens Health       Date:  2022-08-30       Impact factor: 2.742

6.  Treatment Outcomes of Patients With Cervical Intraepithelial Neoplasia or Invasive Carcinoma Who Underwent Loop Electrosurgical Excision Procedure.

Authors:  Jakkapan Khunnarong; Nitinan Bunyasontikul; Siriwan Tangjitgamol
Journal:  World J Oncol       Date:  2021-07-10

7.  The effects of different instruments and suture methods of conization for cervical lesions.

Authors:  Xiaoyu Wang; Lei Li; Yalan Bi; Huanwen Wu; Ming Wu; Jinghe Lang
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

8.  Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.

Authors:  Mengjie Chen; He Wang; Yuejuan Liang; Mingmiao Hu; Li Li
Journal:  BMC Cancer       Date:  2020-09-29       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.